Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Dairy Science|May 23, 2002
Corn silage management I: effects of hybrid, maturity, and mechanical processing on chemical and physical characteristicsL M Johnson, J H Harrison, D Davidson, et al.
Diabetes & Metabolism|November 10, 2019
Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)N L Weir, B T Steffen, W Guan, et al.
The Journal of Endocrinology|June 18, 2002
Implication of alpha4 phosphoprotein and the rapamycin-sensitive mammalian target-of-rapamycin pathway in prolactin receptor signallingR T M Boudreau, S M Sangster, L M Johnson, et al.
Pediatrics|November 5, 1999
Sleep disturbances in children with human immunodeficiency virus infectionL S Franck, L M Johnson, K Lee, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 30, 2013
Hippocampal shape abnormalities of patients with childhood-onset schizophrenia and their unaffected siblingsSarah L M Johnson, Lei Wang, Kathryn I Alpert, et al.
Veterinary Journal (London, England : 1997)|July 20, 2017
Steroids, steroid precursors, and neuroactive steroids in critically ill equine neonatesK A Dembek, K J Timko, L M Johnson, et al.
Journal of Dairy Science|October 24, 2007
Effects of rumen-undegradable protein sources and supplemental 2-hydroxy-4-(methylthio)-butanoic acid and lysine-HCl on lactation performance in dairy cowsL M Johnson-VanWieringen, J H Harrison, D Davidson, et al.
The New England Journal of Medicine|March 24, 1983
Hemorrhagic colitis associated with a rare Escherichia coli serotypeL W Riley, R S Remis, S D Helgerson, et al.
Epidemiology and Infection|October 17, 2013
Yersinia enterocolitica infections associated with improperly pasteurized milk products: southwest Pennsylvania, March-August, 2011A H Longenberger, M P Gronostaj, G Y Yee, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPID W Snyder, N J Bach, R D Dillard, et al.
Pageof 9